INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors

NCT03589651 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable or Metastatic Solid Tumors

Interventions

DRUG: Retifanlimab
DRUG: Epacadostat
DRUG: INCB050465

Sponsor

Incyte Corporation